Gampongan, Rowena T.

HRN: 11-60-79  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2026
CEFUROXIME 1.5GM (VIAL)
05/31/2026
06/01/2026
IVTT
1.5g
Q8h
Non-institutional Delivery
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary TractReproductive Tract    Compliance to guidelines: Compliant To Guidelines